Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
In a significant pivot from long-standing practices, major Wall Street banks are abandoning marijuana and other substance tests for job applicants.
This move signals the growing acceptance of cannabis in the professional world and reflects broader legal and societal shifts.
Here’s how major financial institutions are adjusting their policies, according to Business Insider:
Banks’ Approach To Drug Testing:
The trend among Wall Street financial institutions mirrors a nationwide reassessment of cannabis, influenced by its legal status in multiple U.S. states and shifting public opinion.
The change is partly driven by practical considerations, including the challenges of enforcing strict drug-free policies in regions where cannabis is legal and the need to attract talent in a competitive job market.
Studies and reports highlight a significant drop in companies requiring drug tests, prompted by a combination of legal changes, a reevaluation of the efficacy of such policies, and the recognition of the privacy rights and personal freedoms of employees.
Several U.S. states have enacted laws prohibiting employers from discriminating against employees or job applicants based on cannabis use outside work hours. These legislative shifts recognize the growing consensus that off-duty cannabis consumption does not necessarily impair job performance or workplace safety.
This trend marks a significant shift in how businesses approach cannabis use among their workforce, signaling a new era of employment practices that respect privacy and individual rights while ensuring workplace safety and productivity.
Photo: Beniznga edit of images by lo lo and Paul Einerhand on Unsplash